InvestorsHub Logo
Followers 229
Posts 14674
Boards Moderated 1
Alias Born 03/29/2014

Re: Midasbro post# 194685

Wednesday, 10/24/2018 4:22:22 PM

Wednesday, October 24, 2018 4:22:22 PM

Post# of 701950

‘DCVax® has extended survival of MANY of our glioblastoma patients for more than a year, and some are thriving more than 10 years after their initial diagnosis.’




Those who live to reach 36 months had a KM derived mOS of 88.2 months in the P3 DCVax-L trial. :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News